Robert L. Shapiro PH.D.

Recommended Articles

• The Gut-Brain Connection: How Does Celiac Disease Affect the Brain?

  Celiac Shows Itself in Mysterious WaysCeliac disease, a genetic autoimmune disease triggered by the consumption of gluten, is known for causing intestinal inflammation and an upset stomach, with symptoms like bloating and diarrhea. Though it only affects an estimated one percent of the population, a...

• What Are the Causes and Symptoms of Liver Cirrhosis?

  Cirrhosis is attributed to an abnormal condition which causes a scarring of the liver that damages the functioning of the liver considerably. There are a number of factors that can result in the cirrhosis of the liver such as consuming excessive alcohol, viral hepatitis, other liver disease and so...

• Additional Insight into Children's Sleep Apnea

  It is surprisingly not uncommon for children to show mild forms of sleep apnea due to enlarged tonsils or adenoids, and some of them can usually grow out of it as their body develops and the airway expands to accommodate their growth. Regardless, the severe versions of obstructive sleep-disordered...

• New Cancer Drug in the UK Has Begun Clinical Trials for Advanced Cancer Patients

  People with advanced tumors are often at the very end of a line of treatment options. Despite the many advances we have today in technology and modern medicine, cancer’s puzzle has not yet been solved. Many of these patients’ last days are filled with pain as they spend their last moments...

• Woman with Cystic Fibrosis Celebrates 40th Birthday with 40 Acts of Kindness

  One woman is making it her mission to spread kindness--among anger, hope among fear, and love among hate. Kelly Asbell is that woman.Spending too many years in fearWednesday, March 21, 2018, was Kelly Asbell’s 40th birthday, a date she never imagined seeing. At age ten, Kelly was diagnosed with...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...